DENTSPLY SIRONA Inc. (NASDAQ:XRAY) marked $29.15 per share on Thursday, down from a previous closing price of $29.78. While DENTSPLY SIRONA Inc. has underperformed by -2.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -50.11%, with highs and lows ranging from $59.78 to […]
Dentsply Sirona (XRAY) declared $0.125/share quarterly dividend, in line with previous.Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept. 29.See XRAY Dividend Scorecard…
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) price closed lower on Tuesday, September 27, dropping -1.15% below its previous close. A look at the daily price movement shows that the last close reads $29.69, with intraday deals fluctuated between $29.215 and $30.58. The company’s 5Y monthly beta was ticking 0.95 while its P/E ratio in the trailing 12-month … If You’re Not Bullish On DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Now, You’ll Kick Yourself Later Read More »
Dentsply Sirona''s challenge this year has been ongoing regulatory firestorm since falling out of compliance by not releasing Q1 audited financial statements. Read more here on XRAY stock.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which m
Dentsply Sirona (XRAY) announced Thursday the appointment of Glenn Coleman as its executive vice president and chief financial officer, effective Sept
CHARLOTTE, N.C., Sept. 22, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) as we speak introduced that Glenn Coleman has been appointed Executive Vice […] The post Dentsply Sirona Appoints Glenn Coleman as Chief Financial appeared first on Businessfortnight .
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) concluded the trading at $30.78 on Wednesday, September 21 with a fall of -0.19% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $30.84 and 5Y monthly beta was reading 0.95 with its price kept floating in the … DENTSPLY SIRONA Inc. (XRAY) Stock Behavior Is Not Predictable Read More »
In the current trading session, DENTSPLY SIRONA Inc.’s (XRAY) stock is trading at the price of $31.20, a gain of 1.17% over last night’s close. So, the stock is trading at a price that is -49.00% less than its 52-week high of $61.18 and 2.03% better than its 52-week low of $30.58. Based on the […]
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) closed Thursday at $32.91 per share, up from $31.92 a day earlier. While DENTSPLY SIRONA Inc. has overperformed by 3.10%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -47.18%, with highs and lows ranging from $63.10 to $30.89, whereas […]
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Dentsply Sirona Inc. (“Dentsply”) (NASDAQ: XRAY) breached their fiduciary duties to Dentsply and its shareholders. If you are a Dentsply shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or jpettigrew@scott-scott.com. Scott+Scott is investigat
Dentsply Sirona (XRAY) said Thursday it appointed Simon Campion as president, CEO and member of the board, effective Sept. 12.Campion succeeds John Groetelaars, who served as interim CEO…
CHARLOTTE, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Simon Campion has been appointed President and Chief Executive Officer and will join the Company’s Board of Directors (“Board”), effective September 12, 2022. He succeeds John Groetelaars, who has served as Interim Chief Executive Officer since April 2022. Mr. Groetelaars will continue to serve on the Board.
Dentsply Sirona (XRAY) announces that they received notice from Nasdaq stating that the company remains out of compliance with the listing rules because its 10Q has not been filed on…
Related Stocks: FISV , XRAY , GLW , ROK , BDX ,
Dentures are a type of dental prosthesis used to replace missing teeth. They are typically made from acrylic or metal and are held in place by suction or adhesive. Dentures can be removable or fixed, and they can be partial
A recent update issued by dental product maker Dentsply Sirona (XRAY) on an ongoing investigation has led William Blair to downgrade the stock to Underperform from Market Perform on Friday
Dentsply Sirona Inc (NASDAQ: XRAY ) expects to report Q2 FY22 net sales of over $1.01 billion . Additionally, diluted EPS is expected to be at or above $0.26 and adjusted EPS at or above $0.60. The company said that though sales declined Y/Y due to the unfavorable impact of foreign exchange, the business delivered organic … Full story available on Benzinga.com
Dentsply Sirona (XRAY) on Thursday reported prelim. Q2 results and said it will not be able to file its Q2 report with the SEC by the Aug. 9 deadline due to ongoing internal probe.XRAY…
(PLX AI) – Dentsply Sirona net sales and adjusted EPS expected to be above preliminary first quarter 2022 results.Dentsply Sirona will not be in a position to file its Quarterly Report by the August 9, 2022, deadlineDentsply Sirona q2 adjusted EPS …
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (NASDAQ: XRAY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
NEW YORK, July 29, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022…
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the “Class Period”), of the important August 1, 2022 lead plaintiff deadline .
NEW YORK, July 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the “Class Period”), of the important August 1, 2022 lead plaintiff deadline .
NEW YORK, July 22, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is notifying investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (XRAY: NASDAQ) of a class action securities lawsuit. Dentsply purports to be the world’s largest manufacturer of professional dental products and technologies.
Related Stocks: GOOG , UPS , GOOGL , WSO , XRAY ,
https://www.investing.com/news/pro/dentsply-sirona-pt-lowered-to-41-at-goldman-sachs-432SI-2850289
The market selloff in FY22 has provided compelling opportunities within the health care and medical technology universe. See what this means for XRAY stock.
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Ohio on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (NASDAQ: XRAY ) securities from June 9, 2021 through May 9, 2022, both dates inclusive (the “Class Period”). ”). Investors have until August 1, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
NEW YORK, July 13, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022…
NEW YORK , July 11, 2022 /PRNewswire/ -- Attention Dentsply Sirona Inc. ("Dentsply") (NASDAQ: XRAY) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of all persons or entities that purchased…
NEW ORLEANS, July 8, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 1, 2022 to file lead plaintiff applications in a securities class action lawsuit against…
NEW YORK , July 8, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY ). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/dentsply-sirona-inc-loss-submission-form/?id=29608&from=4 This lawsuit is on behalf of all persons or entities that purchased Dentsply''s common stock between June 9, 2021 , and May 9, … Full story available on Benzinga.com
SAN FRANCISCO, July 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY ) investors who have suffered over $1 million losses to submit your losses now . A securities fraud class action has been filed and certain investors have an opportunity to lead the case. Class Period: June 9, 2021 – May 9, 2022 Lead Plaintiff Deadline: Aug. 1, 2022 Visit: https://www.hbsslaw.com/investor-fraud/XRAY Contact An Attorney Now: XRAY@hbsslaw.com 844-916-0895 DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action: The litigation focuses on DENTSPLY''s assurances that its financial statements fairly presented in all material respects the financial condition of the company. The complaint alleges Defendants orchestrated a scheme to inflate DENTSPLY''s … Full story available on Benzinga.com
SAN FRANCISCO, July 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY) investors who have suffered over $1 million losses to submit your losses now . A securities fraud class action has been filed and certain investors have an opportunity to lead the case.
NEW YORK, July 7, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dentsply investors who were…
NEW YORK, July 6, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022…
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 1, 2022 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (NasdaqGS: XRAY), if they purchased the Company’s shares between June 9, 2021 and May 9, […]
NEW YORK, July 6, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc.. Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, July 5, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY) alleging that the Company violated federal securities laws. This lawsuit is on behalf of all persons or…
The Dental Surgical Equipment Market research report provides all the information related to the industry. It gives the outlook of the market by giving authentic data to its client which helps to make essential decisions. It gives an overview of
SAN FRANCISCO, June 29, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY ) investors who have suffered over $1 million losses to submit your losses now . A securities fraud class action has been filed and certain investors have an opportunity to lead the case. Class Period: June 9, 2021 – May 9, 2022 Lead Plaintiff Deadline: Aug. 1, 2022 Visit: https://www.hbsslaw.com/investor-fraud/XRAY Contact An Attorney Now: XRAY@hbsslaw.com 844-916-0895 DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action: The litigation focuses on DENTSPLY''s assurances that its financial statements fairly presented in all material respects the financial condition of the company. The complaint alleges Defendants orchestrated a scheme to … Full story available on Benzinga.com
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Dentsply Sirona, Inc. (NADSAQ: XRAY), IonQ, Inc. (NYSE: IONQ), Energy Transfer LP (NYSE: ET), and Digital Turbine, Inc. (NASDAQ: APPS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SAN FRANCISCO, June 23, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY) investors who have suffered over $1 million losses to submit your losses now . A securities fraud class action has been filed and certain investors have an opportunity to lead the case.
SAN FRANCISCO, June 23, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY ) investors who have suffered over $1 million losses to submit your losses now . A securities fraud class action has been filed and certain investors have an opportunity to lead the case. Class Period: June 9, 2021 – May 9, 2022 Lead Plaintiff Deadline: Aug. 1, 2022 Visit: https://www.hbsslaw.com/investor-fraud/XRAY Contact An Attorney Now: XRAY@hbsslaw.com 844-916-0895 DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action: The litigation focuses on DENTSPLY''s assurances that its financial statements fairly presented in all material respects the financial condition of the company. The complaint alleges Defendants orchestrated a scheme to … Full story available on Benzinga.com
NEW YORK, June 19, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022…
LOS ANGELES , June 17, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY ). Class Period: June 9, 2021 – May 9, 2022 Lead Plaintiff Deadline: August 1, 2022 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants … Full story available on Benzinga.com
NEW YORK, June 16, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dentsply investors who were…
In the latest trading session,, 0.96 million DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares changed hands as the company’s beta touched 0.94. With the company’s most recent per share price at $35.56 changed hands at -$0.03 or -0.08% at last look, the market valuation stands at $7.84B. XRAY’s current price is a discount, trading about -88.36% off … DENTSPLY SIRONA Inc. (NASDAQ: XRAY): The Stock To Invest In Over The Next Few Months Read More »
Global Orthodontics Market Size, Status, and Forecast for the 2022-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Orthodontics industry, as well as drivers, restraints, PESTLE analysis, historical